"The board and management continue to actively engage with strategic parties and potential partners and will assess opportunities as they arise, with interest received in several indications. Cynata seeks to strengthen its commercialisation strategy by advancing clinical development and undertaking further corporate partnering transactions."
I seem to read something along these lines in the last number of quarterlies
Ann: Quarterly Activity Report & Appendix 4C, page-2
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.010(3.70%) |
Mkt cap ! $50.29M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 28.0¢ | $6.147K | 21.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23769 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 132 | 2 |
View Market Depth
| Last trade - 10.13am 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
28.0¢ |
Change
0.010 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 28.0¢ | 28.0¢ | 28.0¢ | 5225 | ||
| Last updated 11.18am 24/05/2024 ? | |||||
| CYP (ASX) Chart |